Silk Road Medical (SILK)
(Delayed Data from NSDQ)
$27.02 USD
+0.01 (0.04%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $27.04 +0.02 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
SILK 27.02 +0.01(0.04%)
Will SILK be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SILK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SILK
Edwards Lifesciences (EW) Q2 Earnings Match Estimates
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
SILK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
Strength Seen in Silk Road Medical (SILK): Can Its 24.0% Jump Turn into More Strength?
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
Other News for SILK
Boston Scientific Announces Results for Second Quarter 2024
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
A Closer Look at 4 Analyst Recommendations For Silk Road Medical
Silk Road Medical just downgraded at Stifel, here's why
3 Record-Breaking Stocks With More Room to Run